Filtered by speaker:Marty Makary×
Searching...
2 results for “regulatory approval” by Marty Makary
call it excess regulatory burden that's causing these extended timelines on drug approvals. Just just to kind of frame it up a little bit. Sure. So there's an something called the IND, investigational new drug registration process. That's step one. M
13:29 / 14:30
from transcript13:29 – 14:30
...it excess regulatory burden that's causing these extended timelines on drug approvals. Just just to kind of frame it up a little bit. Sure. So there's an something called the IND, investigational new drug registration process. That's step one. Most o
12:39 / 13:53
from transcript12:39 – 13:53
Have a podcast?
Run your podcast through Clypt
Get ranked clips, hooks, and ready-to-post copy from your own episodes. Free to try.